Medicine Description sprycel 50 mg
sprycel 50 mg tablets is a medication that functions as a tyrosine kinase inhibitor, specifically targeting the BCR-ABL fusion protein that is created by the Philadelphia chromosome abnormality. This abnormality results in the production of a constitutively active tyrosine kinase, driving the proliferation and survival of malignant cells. By binding to this fusion protein, dasatinib effectively halts downstream signaling pathways involved in cancer cell division and survival, thereby inducing apoptosis and inhibiting tumor growth.
Indications and Uses of sprycel 50 mg tablets
- Treatment of chronic myeloid leukemia (CML), including chronic phase, accelerated phase, and blast phase.
- Treatment of acute lymphoblastic leukemia (ALL) in patients with the Philadelphia chromosome.
- Treatment of Philadelphia chromosome-positive (Ph+) leukemias.
Side Effects of sprycel 50 mg tablets
- Common side effects may include nausea, vomiting, diarrhea, and fatigue.
- Notable side effects can encompass fluid retention, bleeding events, and cardiovascular complications.
- Some patients may experience skin rash, pruritus, and headaches.
Storage and Handling
Store sprycel 50 mg tablets at room temperature, ideally between 20°C to 25°C (68°F to 77°F), away from excess moisture and direct sunlight. Keep the medication out of reach of children.
Patient Advice and Precautions
Patients should be advised to monitor for signs of bleeding or infection and to report any unusual symptoms to their healthcare provider promptly. Regular blood tests may be necessary to monitor treatment efficacy and side effects. It is essential to follow the prescribing physician's guidance and inform them about any other medications being taken, to avoid potential drug interactions.